Compare INDV & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | UVV |
|---|---|---|
| Founded | N/A | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 1.1B |
| IPO Year | 2014 | 1994 |
| Metric | INDV | UVV |
|---|---|---|
| Price | $35.42 | $43.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 243.3K |
| Earning Date | 06-08-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 6.25% |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | $1,239,000,000.00 | ★ $2,885,078,000.00 |
| Revenue This Year | N/A | $0.67 |
| Revenue Next Year | N/A | $0.10 |
| P/E Ratio | $21.28 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.56 | $43.07 |
| 52 Week High | $42.81 | $59.38 |
| Indicator | INDV | UVV |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 27.04 |
| Support Level | $32.06 | N/A |
| Resistance Level | $35.54 | $54.11 |
| Average True Range (ATR) | 0.85 | 0.85 |
| MACD | 0.22 | -0.01 |
| Stochastic Oscillator | 80.09 | 5.83 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Universal Corp is an international leaf tobacco supplier. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, the Philippines, Germany, and Other Countries, with the majority of revenue from the USA.